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Abstract
Background: The use of lactic acid bacteria as vehicles to delivery antigens to immunize animals is a
promising issue. When genetically modified, these bacteria can induce a specific local and systemic immune
response against selected pathogens. Gastric acid and bile salts tolerance, production of antagonistic
substances against pathogenic microorganisms, and adhesive ability to gut epithelium are other important
characteristics that make these bacteria useful for oral immunization.
Results: Bacteria isolated on de Man, Rogosa and Sharpe medium (MRS) from different gastrointestinal
portions of broiler chicks were evaluated for their resistance to artificial gastric acid and bile salts,
production of hydrogen peroxide, and cell surface hydrophobicity. Thirty-eight isolates were first typed at
species level by PCR amplification of 16S-23S rRNA intergenic spacers using universal primers that anneal
within 16S and 23S genes, followed by restriction digestion analyses of PCR amplicons (PCR-ARDRA). An
expression cassette was assembled onto the pCR2.1-Topo vector by cloning the promoter, leader
peptide, cell wall anchor and terminator sequences derived from the laminin binding S-layer protein gene
of L. crispatus strain F5.7 (lbs gene). A sequence encoding the green fluorescent protein (GFP) was inserted
as reporter gene, and an erythromycin resistance gene was added as selective marker. All constructs were
able to express GFP in the cloning host E. coli XL1-Blue and different Lactobacillus strains as verified by
FACS and laser scanning confocal microscopy.
Conclusion: Lactobacillus isolated from gastrointestinal tract of broiler chickens and selected for probiotic
characteristics can be genetically modified by introducing an expression cassette into the lbs locus. The
transformed bacteria expressed on its cell wall surface different fluorescent proteins used as reporters of
promoter function. It is possible then that similar bacterial model expressing pathogen antigens can be
used as live oral vaccines to immunize broilers against infectious diseases.
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Background
Probiotics are food or preparations containing live micro-
organisms, traditionally regarded as safe for human and
animal use. When ingested in sufficient numbers, probi-
otics are believed to play an important role in the control
of host intestinal microbiota and modulation of host
immune responses [7]. Both local and systemic immune
responses can be modulated by probiotics, with produc-
tion of a set of cytokines such as IFN-γ, TNF-α, IL-6 and IL-
12, and nitric oxide (NO) [8,26]. The increasing regula-
tions and bans on the use of anticoccidial drugs in com-
mercial poultry production, urges the need for novel
approaches and alternative strategies to control avian
eimeriosis. Probiotics are an alternative to antimicrobial
drugs commonly employed as growth-promoter to broil-
ers, avoiding drug residues to accumulate in animal car-
Table 1: Lactobacillus strains isolated from different portions of chicks gastrointestinal tract, species identification by PCR-ARDRA and 
some probiotic features
Isolate Species identificationa Bile salt inhibition (%)b Hydrophobicity (%)c H2O2 productiond
Gizzard
1M14C L. reuteri 14 89 nde
1M14E L. johnsonii 59 35 +
2M14C L. reuteri 21 58 ++
2M14L L. acidophilus 58 52 +
2M14E L. acidophilus 92 88 +
3M14C L. reuteri 25 42 +
3M14L L. johnsonii 24 61 +
4M14C L. reuteri 19 64 +
4M14L L. reuteri 54 36 +
4M14E L. acidophilus 96 5 -
5M14C L. reuteri 18 78 +
5M14E L. vaginalis 100 75 ++
Small intestine
1D14C L. salivarius 13 60 +++
2D14C L. vaginalis 71 67 ++
2D14E L. acidophilus 46 76 -
3D14C L. reuteri 13 83 ++
3D14L L. crispatus 36 88 ++
4D14C L. reuteri 13 88 +
4D14L L. reuteri 20 57 +
5D14E L. acidophilus 08 3-
Large intestine
1G14E Lactobacillus 27 78 -
2G14E L. acidophilus 37 55 -
3G14C L. reuteri 14 67 ++
3G14L L. johnsonii 22 45 -
4G14C L. vaginalis 37 25 ++
4G14L L. reuteri 40 35 ++
4G14E L. vaginalis 100 72 -
5G14C L. salivarius 43 66 +++
5G14L L. crispatus 41 35 +
Ceca
2C14E L. acidophilus 72 55 -
2C14L L. acidophilus 10 78 -
3C14C L. reuteri 08 4 + +
3C14L L. johnsonii 24 83 +
3C14E L. acidophilus 80 64 +
4C14C L. salivarius 43 92 +++
4C14L L. acidophilus 73 79 nd
5C14C L. salivarius 41 83 +++
5C14E L. acidophilus 06 4+
aIsolates typed by 16S-23S rRNA PCR-ARDRA according to Moreira et al. (2005)
bPercentage of optical density reduction after 6 h growing in MRS containing 0.3% bile salts
cPercentage of microbial adhesion to xylene
dH2O2 production in TMB-Plus (+++, dark blue; ++, blue; +, light blue/blue border; -, none)
eNot determinedBMC Biotechnology 2006, 6:2 http://www.biomedcentral.com/1472-6750/6/2
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casses and in the meat [11]. In ourdays, most of the
probiotic preparations studied or commercialised con-
tains lactic acid bacteria (LAB).
Criteria for screening of Lactobacillus strains for use as pro-
biotics includes functional characteristics such as the abil-
ity to resist environmental conditions found in the
digestive tract (low gastric pH and bile salts), to antago-
nize or competitively exclude pathogens by secretion of
antimicrobial substances or to compete for nutrients and
adhesion sites. LAB can produce different antimicrobial
components such as organic acids, hydrogen peroxide,
carbon peroxide, diacetyl, low molecular weight antimi-
crobial substances, bacteriocins, and adhesion inhibitor
[24]. Production of hydrogen peroxide by Lactobacillus has
been considered an important ecological factor that
allows them to dominate some ecosystems like human
vagina [20]. The adhesiveness of LAB may involve passive
forces, electrostatic interactions, hydrophobic steric
forces, lipoteicoic acids and lectins [24]. The hydrophobic
nature of the outermost surface of microorganisms facili-
tates the adhesion of bacteria to host epithelium, confer-
ring an advantage for competition and colonization in the
gastrointestinal tract [28].
Besides their well known nutritional benefits and almost
null pathogenicity, showed as millenary food supple-
ments, the use of LAB as bacterial systems to express het-
erologous proteins or as vehicles to carry immunizing
antigens after genetic modification is becoming a promis-
ing issue [18,22]. However, the successful expression of
heterologous proteins in LAB depends on the promoter
compatibility between the species or strains used as vector
or hosts [13]. As pointed out by Pouwels et al. [18], the
control of transcription and translation may differ greatly
between two Lactobacillus  species, implying that the
knowledge generated for one organism may not simply be
extrapolated to another. Genes that are efficiently
expressed in one Lactobacillus species are not necessarily
expressed in other species, or are expressed with different
efficiency and/or with a different regulatory mechanism.
Therefore, the correct typing of new isolates with probi-
otic properties is crucial for the development of a success-
ful oral vaccine.
L. crispatus strains possess different S-proteins capable to
bind proteins of intestinal extracellular matrix such as col-
lagens (CbsA protein) and laminin (LbsA protein). The S-
promoter responsible for the high level of transcription of
stable mRNAs coding the S-protein monomers, which are
capable to crystallizing into regular arrays and cover the
Lactobacillus cell wall [5], is a good candidate to direct
mRNA synthesis of chimerical genes for expression of het-
erologous proteins at the S-layer. The C-terminal one-
third region of these S-proteins is responsible for the
Growth inhibition by bile salts of three different strains of L  acidophilus Figure 1
Growth inhibition by bile salts of three different 
strains of L. acidophilus. L. acidophilus strains 5C14E (A), 
2G14E (B) and 2M14E (C) were grown to an OD600 nm of 0.6 
(logarithmic phase) and 1 % inoculated in MRS broth contain-
ing or not 0.3 % oxgall in a microtiter plate. Readings at 
OD600 nm were taken at 15 min intervals during 12 h of incu-
bation at 37°C in a Microplate Spectrophotometer System 
SpectraMax 340. Percentage of growth inhibition was calcu-
lated after 6 h as (1 – ABS/ACT) × 100.BMC Biotechnology 2006, 6:2 http://www.biomedcentral.com/1472-6750/6/2
Page 4 of 11
(page number not for citation purposes)
attachment to the peptidoglycan layer and incorporation
of that sequence to chimerical proteins halts them to bac-
terial surface [25].
The aim of this study was to develop a transforming vector
to express heterologous proteins using novel strains of
Lactobacillus  isolated from different gastrointestinal
regions of broiler chickens and previously selected for
some probiotic properties.
Results
Thirty-eight isolates of bacteria were obtained from differ-
ent gastrointestinal portions of five broiler chickens and
selected as Gram-positive non-sporing, catalase negative,
and presenting rods with diverse sizes. Table 1 summa-
rizes the characteristics these isolates. Species identifica-
tion by 16S-23S rRNA ARDRA showed that 7 different
species were recovered in the following order: 12 L. reuteri
(31,6%), 11 L. acidophilus (29,0%), 4 L. johnsonii (10,5%),
4 L. salivarius (10,5%), 4 L. vaginalis (10,5%), 2 L. crispatus
(5,3%), and 1 Lactobacillus spp (2,6%). L. reuteri and L.
acidophilus  were more frequently isolated from gizzard
and ceca, respectively. The highest biodiversity in term of
number of different Lactobacillus  species was found in
intestines.
The strains were screened for the following probiotic cri-
teria: in vitro gastric juice and bile salts resistance, surface
hydrophobicity, and production of H2O2. All strains were
highly resistant to acidic pH, showing low (about 5%) or
no decrease of viable cell numbers 3 h after incubation at
pH 2.5 (data not shown). On the other hand, bile salts tol-
erance varied markedly between strains (Table 1), even for
same species (Fig. 1). Some isolates showed no or few
growth inhibition in MRS broth supplemented with 0.3%
oxgall, while others were moderately or highly susceptible
to bile salts. The MATS (Microbial Adhesion To Solvents)
method was used to evaluate the hydrophobic/
hydrophilic cell surface properties of Lactobacillus isolates
and to compare with those of other probiotic bacteria
[16]. The bacterial adhesion to xylene at a high ionic
strength of 0.1 M (pH 6.2) reflects cell surface hydropho-
bicity or hydrophilicity because electrostatic interactions
are absent. Our results indicated that most of Lactobacillus
isolates (79%) have hydrophobic surfaces (Table 1). Inter-
estingly, all Enterococcus strains co-isolated in this study
were highly hydrophilic (data not shown). The antagonis-
tic capacity was evaluated by the production of H2O2 in
TMB-Plus agar medium under anaerobic condition fol-
lowed by air exposure. The results showed that most of
Lactobacillus strains (75%) produced H2O2 (Table 1). The
four isolates typed as L. salivarius (1D14C, 5G14C, 4C14C
and 5C14C) produced more H2O2 than other species
while seven L. acidophilus, one L. johnsonii (3G14L) and L.
vaginalis (4G14E) were unable to produce H2O2.
In order to develop an expression vector for genetic
manipulation of these new isolates of Lactobacillus, we
PCR amplified the nucleotide sequences of the promoter,
the leader peptide, the cell wall anchor and the terminator
of lbs gene using genomic DNA of L. crispatus strain F5.7
(primers depicted in Table 2). As shown in Figure 2, a 344
pb fragment encompasses the regions containing the pro-
moter, 5' untranslated portion and the leader peptide of
the lbs gene. Figure 2 upper panel shows the alignment of
this PCR product cloned into the pCR2.1-Topo and the
sequence of the lbsA gene of L. crispatus (accession number
AB110090). Figure 2 lower panel shows the alignment of
the 600 bp PCR product encoding part of the coding
region of lbsB gene that corresponds to the putative cell
wall anchor and the terminator (accession number
AB110091). These two fragments of the lbs  gene were
assembled into an expression cassette to produce recom-
binant proteins in fusion with the C-terminus of Lbs pro-
tein, which should allow the heterologous protein to be
attached to the bacteria cell wall. The expression cassette
was constructed into pCR2.1-Topo backbone opposite to
the lac promoter (Fig. 3). This plasmid was chosen
because it harbours replication origin for E. coli (pUC ori-
gin), which is not functional in Gram-positive bacteria
such as Lactobacillus spp. Thus, we expected to integrate
the expression cassette into the chromosome by homolo-
gous recombination within the S-layer protein locus,
present in almost all species isolated from chicken [2]. The
plasmid integration has probably occurred since we have
not detected on gel electrophoresis of DNA extracted from
transformed, erythromycin resistant and GFP-positive
Lactobacillus, any DNA band that might correspond to
plasmid DNA (-data not shown).
The expression of gfp mut2 gene in E. coli XL1-Blue trans-
formed with the pLBS-GFP-EmR plasmid results in green
fluorescent bacteria, as measured by FACS at 488 nm exci-
tation wavelength (data not shown). The transformation
of chicken Lactobacillus isolates F5.7, 1M14C, 1M14E
and 3M14L, and the human strain of L. delbrueckii UFV
H2b20, with the plasmid pLBS-GFP-EmR was also suc-
cessful as evaluated by PCR amplification of the gfp gene
from the transformants (data not shown). However, the
analysis by FACS was unsuccessful due to a strong green
auto fluorescence displayed by all non-transformed con-
trol Lactobacillus when excited at 488 nm. To overcome
this problem, we performed confocal microscopy analyses
that could discriminate the fluorescence from the bacteria
expressing GFP and the auto fluorescence using different
excitation wavelengths. As shown in Figure 4, by exciting
at 458 nm we were able to detect the control bacteria as
non-fluorescent while the most of cells transformed with
the pLBS-GFP-EmR plasmid showed a strong green fluo-
rescence.BMC Biotechnology 2006, 6:2 http://www.biomedcentral.com/1472-6750/6/2
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Discussion
In order to exert health-promoting effects, probiotic bac-
teria need to resist and survive the inhospitable condi-
tions of chicken gastrointestinal tract. The fact that a high
percentage of Lactobacillus cells adhered to xylene, an apo-
lar solvent, demonstrated hydrophobic cell surface of
these strains. However, some Lactobacillus isolates and all
Enterococcus co-isolated strains showed more hydrophilic
cell surface properties. Many previous studies on the phys-
icochemistry of microbial cell surfaces have shown that
the presence of (glyco-) proteinaceous material on the cell
surface results in higher hydrophobicity, whereas
hydrophilic surfaces are generally associated with the
presence of polysaccharides [17]. The high hydrophobic-
ity of most strains isolated in this prospecting study could
facilitate bacteria-host cells interactions and improve anti-
gen delivering to the immune cells present in the gastroin-
testinal associated lymphoid tissue (GALT).
The viability of probiotics is not an essential requirement
for some antigen delivery since killed bacteria also stimu-
late the host immune system when ingested in sufficient
numbers [16]. However, various biotherapeutic mecha-
nisms are dependent on metabolic activity such as the
direct competition for nutrients or secretion of antimicro-
bial substances. For the efficiency of an oral vaccine, cell
viability is also probably fundamental. However, bacteria
entering the gastrointestinal tract must be able to resist to
certain local stresses such as the gastric pH and bile salts.
In this context, the stress resistance showed by the Lacto-
bacillus isolated in the present study would be important
for these bacteria to exert a probiotic or oral live vaccine
action. Since many pathogens, including Eimeria spp. spo-
rozoites [10], are very sensitive to H2O2, its production by
most of the Lactobacillus strains also could assure their suc-
cess in the gut ecosystem and improve the vaccination
process.
Non-pathogenic lactic acid bacteria (LAB) are attractive as
live carriers to deliver protective antigens to the mucosal
immune system. Lactococcus lactis is the LAB system for
antigen delivery better established and used actually. Sev-
eral molecular tools were constructed to allow antigen
expression in three cellular locations, intracellular,
secreted or anchored to the cell wall [3], combined to the
adjuvant expression of IL-12 [4]. Such studies with a novel
mucosal vaccine based on live Lactococci expressing E7
Antigen anchored to the cell surface and a secreted form
of IL-12 showed that this prophylactic immunization can
provide long-lasting immunity in mice against human
Papillomavirus type 16-induced tumors and, also the
therapeutic immunization with L. lactis recombinant
strains induced regression of palpable tumors in treated
mice a week after tumoral cells injection [4]. However,
Lactococcus lactis is not a probiotic bacterium, being una-
ble to adhere to the intestine cells and competitively
exclude pathogens. Both persisting (Lactobacillus
plantarum  NCIMB8826/pMEC127) and non-persisting
(Lactococcus lactis MG1363/pMEC46) strains of lactic acid
bacteria have been evaluated by Grangette et al. [9] and
seem to elicit a very strong specific and protective humoral
response by the systemic and nasal routes of administra-
tion. The same authors have also shown that persistence
and viability of the strain impacts on its immunogenicity
and on the level of protection it may induce, indicating
that Lactobacillus is more efficient than Lactococcus as a vac-
cine delivery vehicle [9]. Recently, the development of an
efficacious vaccine against infection with Helicobacter felis,
delivered by recombinant Lactobacillus strains producing
H. pylori urease B (UreB) subunit, elicited UreB-specific
antibodies and results in a decreased H. felis load in the
stomachs of vaccinated mice. This was the first report of
successful induction of partial protection against a patho-
gen with a mucosal prime-boost regimen in which recom-
binant Lactobacillus strains were used as antigen-delivery
vehicles [6].
A new plasmid for genetic transformation of Lactobacillus
species allowing expression of heterologous proteins
attached to the cell wall components was successfully con-
structed into an E. coli plasmid vector backbone. This plas-
mid was able to transform E. coli XL1-Blue cloning host
from non-fluorescent to green fluorescent cells, which
could be measured by FACS analyses or easily visualized
Table 2: Primers used to amplify the portions of S-layer protein gene of Lactobacillus crispatus (lbs), the green fluorescent protein gene 
(gfp mut2), and the erythromycin gene (ermAM) used as selective marker, respectively.
Primer sequence Amplicon Size (bp)
5'GGATCCCGGTCATTTTAACTTGCTA 3'
5'CTCGAGGATATCTGCAGCGTTAACAGAAACAGCTG 3' lbs promoter plus leader peptide 344
5'GAATTCATGCACAACGCATTCTTCTATG 3'
5'AAGCTTCAGAAGATCCTATTAGAACTGTATGTTTAG 3' lbs anchor plus terminator 600
5'CTCGAGGCTAGTAAAGGAGAAGAACTTTTCACT 3'
5'GAATTCTGCTTTGTATAGTTCATCCATGCCATG 3' gfp mut2 720
5'GGGCCCTCTAGCACAAAAAGAAAAACG 3'
5'GGATCCTCTAGAGTCTAGGGACCTCTTTAGC 3' erm AM 1200BMC Biotechnology 2006, 6:2 http://www.biomedcentral.com/1472-6750/6/2
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Alignments of Lactobacillus crispatus Lbs gene sequences and PCR amplified sequences of L. crispatus strain F5.7 used to assem- ble the expression cassette of plasmid pLBS-GFP-EmR Figure 2
Alignments of Lactobacillus crispatus Lbs gene sequences and PCR amplified sequences of L. crispatus strain 
F5.7 used to assemble the expression cassette of plasmid pLBS-GFP-EmR. Upper panel shows the promoter plus 
leader peptide sequences aligned to LbsA gene and lower panel shows the C-terminal anchor plus terminator sequences 
aligned to LbsB gene.BMC Biotechnology 2006, 6:2 http://www.biomedcentral.com/1472-6750/6/2
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by standard fluorescence microscopy using fluorescein
isothiocyanate (FITC) filter settings. Transformation of
four different species of Lactobacillus, L. crispatus, L. johnso-
nii, L. reuteri and L. delbrueckii, from chicken or human
origin, was also successful despite an unexpected strong
green autofluorescence of non-transformed cells, reported
here for the first time. Although the autofluorescence of
native lactobacillus cells made FACS analyses or standard
fluorescence microscopy not applicable, it could be abol-
ished by exciting GFP at a wavelength lower than 488 nm
using a laser confocal microscopy set at 458 nm. This
could explain the constant use of the UV mutant of GFP
by others researchers instead gfp mut2 or mut3 genes [8].
Usually, intrinsic problems related to the genetic modifi-
cation could arise after the selection of novel isolates such
as the presence of restriction/modification enzymes
which could interfere with the establishment of new exog-
enous plasmids. Also, the presence of cryptic plasmids
may result in incompatibility with the exogenous vector,
as well as genetic exchange between plasmid from differ-
ent bacteria present in the gastrointestinal tract. Our strat-
egy to avoid these problems was to include in the
characterization of the probiotic potential of the novel
isolates, electrophoretic analyses for the presence of extra-
chromosomal DNA elements and to exclude those strains
bearing endogenous plasmids. The persistence of the
introduced plasmid was monitored through the detection
of the new genetic traits such as the antibiotic resistance
and gfp gene expression as well as by PCR analyses of the
GFP sequence. Also, GFP expression was detected after
growing for several generations in the absence of drug
selection.
Conclusion
Thirty-eight Lactobacillus strains were isolated from gas-
trointestinal tract of free-range chicks. Bacteria selected for
some probiotic features (gastric juice and bile salts toler-
ance, high surface hydrophobicity and production of
hydrogen peroxide) expressed the reporter protein GFP
after transformation using a plasmid vector carrying an
expression cassette assembled with lbs  gene sequences.
These results are currently being applied in our laborato-
ries to develop an oral live vaccine to protect broiler chicks
against eimeriosis, a major poultry disease.
Methods
Chickens
Five 14-day-old broiler chickens were raised under natural
conditions and received commercial diet for pullets and
water ad libitum, without any kind of medication (no vac-
cination, antibiotics, hormones or coccidiostatics).
Bacteria isolation
Chickens were sacrificed by cervicaldislocation and giz-
zard, small intestine, large intestine, and ceca removed
aseptically. In a laminar flow hood, samples were placed
into sterile tubes containing 0.9% saline and homoge-
nized with a glass rod. Decimal dilutions in saline were
plated onto MRS agar and kept for 48 h at 37°C in anaer-
obiosis. Bacteria isolates, previously selected as described
above (partially identified as pertaining to Lactobacillus
genus), were cultured in de Man, Rogosa and Sharpe
broth (MRS, Difco, Detroit, MI, USA) after inoculation
with 1% of a fresh stationary culture and incubated in an
anaerobic chamber (Forma Scientific Co., OH, USA) con-
taining an atmosphere of 85% N2, 10% H2 and 5% CO2).
L. crispatus strain F5.7 was gently provided by Prof. Eli-
nalva Maciel Paulo (Universidade Estadual de Feira de
Santana, BA, Brazil), and the human strain UFV H2b20 of
L. delbrueckii was gently provided by Dr. Célia Alencar de
Moraes, Universidade Federal de Viçosa, MG, Brazil).
Escherichia coli XL1-Blue was from Stratagene, CA, USA. E.
coli was grown aerobically in Luria-Bertani (LB) medium.
All the bacteria were stored at -80°C in respective broth
with 30% glycerol.
Plasmid pLBS-GFP-EmR constructed to transform chicken  Lactobacillus Figure 3
Plasmid pLBS-GFP-EmR constructed to transform 
chicken Lactobacillus. The promoter, leader peptide, C-
terminal anchoring and terminator sequences of lbs gene of L. 
crispatus strain F5.7 were PCR amplified, cloned and assem-
bled by overlapping restriction fragments onto pCR2.1-
TOPO vector. The genes ermAM and gfp mut2 were also 
PCR amplified from other plasmids and used as selective 
marker and reporter gene, respectively.BMC Biotechnology 2006, 6:2 http://www.biomedcentral.com/1472-6750/6/2
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Confocal scanning laser micrographs of GFP fluorescence of transformed Lactobacillus delbrueckii Figure 4
Confocal scanning laser micrographs of GFP fluorescence of transformed Lactobacillus delbrueckii. (A – C) 
Genetically transformed lactobacillus with plasmid pLBS-GFP-EmR, and (D – F) control cells. Bacteria were grown overnight, 
washed, killed with sodium azide, and photographed under a laser scanning microscope (LSM) at scale of 54,8 × 54,8 µm. (C) 
Represents merged images of (A,B), and (F) represents merged images of (D,E).BMC Biotechnology 2006, 6:2 http://www.biomedcentral.com/1472-6750/6/2
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DNA extraction
Chromosomal DNA was isolated from overnight cultures
of Lactobacillus sp in 10 ml MRS broth at 37°C. After wash-
ing the cells with 10 ml of deionised water, the pellet was
resuspended in 1 ml of 5 M LiCl and incubated during 1
h under constant shaking. Cells were washed once more
with 1 ml of deionised water and the pellet was suspended
in 1 ml of protoplasting buffer (25 mM sucrose, 50 mM
Tris HCl pH 8.0, 10 mM EDTA, 10 mg of lysozyme ml-1,
100 µg of RNaseA ml-1). After incubation during 1 h at
37°C and centrifugation at maximum speed in a micro-
centrifuge for 5 min, the pellet was resuspended in 500 µl
of protoplasting buffer without sucrose and lysozyme,
and 100 µl of 10% sodium dodecyl sulphate were added
to allow cells lysis. The mixture was extracted once with
phenol, with phenol-chloroform-isoamyl alcohol
(25:24:1) and with chloroform-isoamyl alcohol (24:1).
After isopropanol precipitation the DNA was dissolved in
100 µl of TE buffer.
PCR-ARDRA of 16S-23S rRNA intergenic spacers
Lactobacillus  isolates were identified to species-level by
16S-23S rRNA PCR-ARDRA according to Moreira et al.
[14] using universal primers annealing into conserved
regions of 16S and 23S rRNA genes [27]. PCR amplicons
were digested by a set of 11 restriction enzymes and elec-
trophoresed in a 1.4% agarose gel and visualized by UV
transillumination after ethidium bromide staining. All
restriction enzymes were purchased from Promega Corpo-
ration (Madison, WI, USA).
Screening criteria for probiotic properties
Gastric juice tolerance: Lactobacillus stationary phase cul-
tures were diluted 10 fold in simulated gastric juice (NaCl
2 g l-1, pepsin 3.2 g l-1, pH adjusted to 2.5 with concen-
trated HCl) and incubated at 37°C for 3 h. Bacteria viabil-
ity was evaluated by plating 0.1 ml aliquots of serial
dilutions from control (cells in saline) and gastric juice
treated cells onto MRS agar. Colony forming units (cfu)
were enumerated after incubation at 37°C during 24 h
and the percentage of growth inhibition was calculated as
(1 – log cfuAGJ/log cfuCT) × 100 [15], where cfuAGJ and
cfuCT were the counts for simulated gastric juice and con-
trol, respectively.
Bile salts tolerance: Bile tolerance was evaluated according
to Walker and Gilliland [29] adapted to microtiter plates.
Briefly,  Lactobacillus  strains were fresh grown until an
OD600 nm of 0.6 and 1% inoculated in MRS broth contain-
ing or not 0.3 % oxgall (Oxoid Co.) in a microtiter plate.
Then, OD600 nm were determined at 15 min intervals dur-
ing 12 h of incubation at 37°C in a Microplate Spectro-
photometer System SpectraMax 340 (Molecular Devices,
CA, USA). The percentage of growth inhibition was calcu-
lated as (1 – ABS/ACT) × 100 for 6 h of incubation.
Surface hydrophobicity: Microbial adhesion to solvents
(MATS) was measured to evaluate the hydrophobicity of
bacterial cell surface [12,17]. Lactobacillus stationary phase
cultures were centrifuged, washed twice and adjusted to
an OD600 nm of 0.6 with 0.1 M KNO3, pH 6.2 (A0). A vol-
ume of 0.2 ml of xylene was added to 1.2 ml of cell sus-
pension and after a 10 min pre-incubation at room
temperature, the two-phase system was mixed on a vortex
for 2 min. The aqueous phase was removed after 30 min
and its OD600 nm was measured (A1). The percentage of
MATS was calculated as (1 – A1/A0) × 100. Percentage val-
ues smaller than 50% were considered as hydrophilic, and
values higher than 50% as hydrophobic.
Hydrogen peroxide formation: H2O2-producing strains
were identified by an agar medium assay optimised to
detect H2O2 production according to Rabe & Hillier [19].
Briefly, 2 µl of Lactobacillus stationary phase cultures were
spotted onto the surface of TMB-Plus agar supplemented
with 3,3',5,5'-tetramethylbenzidine (TMB) and horserad-
ish peroxidase, and incubated at 37°C for 18 h in an
anaerobic chamber. Then, plates are exposed to air for 30
min, and a blue pigment appears if H2O2 was produced.
The intensity of blue colour was assigned as +++ if was
dark blue (almost black), ++ if was blue, + if was bluish
generally with a blue border, and – if colour was absent.
Cloning of the PCR-amplified products
The typical reaction mixture contained 10 pmol of each
primer, 0.2 mM of each deoxyribonucleotide triphos-
phate, reaction buffer with 1.5 mM MgCl2, 5 U of Taq
DNA polymerase (Phoneutria Biotecnologia & Serviços,
Brazil), and 10 ng of template DNA. PCR products were
cleaned-up using the Concert™ Rapid PCR Purification
System and cloned in E. coli XL1-Blue into pCR2.1-TOPO
vector using the Invitrogen TOPO TA cloning kit (Invitro-
gen Life Technologies, Carlsbad, USA). PCR was per-
formed on cell lysates of ampicillin-resistant
transformants using M13 specific primers to confirm the
size of the inserts. Inserts were digested with restriction
enzymes, excised from the gel and purified with the Con-
cert™ Rapid Gel Extraction System according to the manu-
facturer's instructions (Invitrogen Co.).
Plasmid DNA preparation and transformation
Plasmid DNA from E. coli was isolated using the commer-
cial kit GFX™ Micro Plasmid Prep kit (Amersham Bio-
sciences, Piscataway, NJ, USA) by alkaline lysis method. E.
coli XL1-Blue was used as host strain for the construction
of the plasmids, and chemically competent cells were
transformed according to the manufacturer's procedure.
Lactobacillus strains were electrotransformed with 1–2 µg
of pLBS-GFP-EmR plasmid according to the optimised
procedure of Serror et al. [23].BMC Biotechnology 2006, 6:2 http://www.biomedcentral.com/1472-6750/6/2
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Plasmid constructions
Plasmids were constructed using standard molecular clon-
ing and PCR fusion (overlap extension) techniques [21].
Primers were purchased from Invitrogen Life Technolo-
gies (São Paulo, Brazil) and Integrated DNA Technologies,
Inc. (Coralville, IA, USA), and are listed in Table 1. Plas-
mid pLBS-GFP-EmR (Fig. 3) was designed to contain the
'backbone' elements of the cloning vector pCR2.1-Topo:
the replication determinants (pUC ori), and ampicillin
and kanamycin resistance markers for E. coli. The Lactoba-
cillus  specific sequences were PCR amplified from
genomic DNA of L. crispatus strain F5.7 to assemble the
expression cassette containing the lbs  promoter, leader
peptide, anchor and terminator sequences. Homologous
sequences to the anchor region of Lbs are found in other
S-layer proteins from different Lactobacillus species, such
as Slp of L. acidophilus (accession X89375, X89376), SlpH
of L. helveticus (accession X91199, X92752), Lgs of L. gall-
inarum (accession AY597259, AY597266), Slp of L. sunto-
ryeus (accession AY641395), Cbs of L. crispatus (accession
AF001313, AF079365), with nucleotide identities higher
than 80% to 90%. These nucleotide stretches can be
enough to allow plasmid integration at lbs  locus via
homologous recombination, otherwise it will be unable
to propagate in Lactobacillus. An erythromycin resistance
marker (ermAM) was amplified from plasmid pRV566.
The Aequorea victoria GFP was PCR amplified from com-
mercial plasmid (Clontech, Palo Alto, CA, USA) and used
as reporter gene to test the expression of heterologous pro-
teins.
Sequencing and sequence analysis
DNA sequencing was carried out at the Núcleo de Análise
de Genoma e Expressão Gênica (NAGE), Instituto de
Ciências Biológicas, UniversidadeFederal de Minas
Gerais, Belo Horizonte, MG, Brazil, using a DYEnamic™
ET Dye Terminator Cycle Sequencing kit for MegaBACE™
DNA Analysis Systems (Amersham Biosciences, USA) in
combination with a MegaBACE™ 1000 automated
sequencing system. Both polynucleotide strands of the
cloned DNA were sequenced, using M13 forward and
reverse primers. The sequences obtained were compared
to sequences held in GenBank DNA database using the
BLAST algorithm [1].
Confocal scanning laser microscopy
Confocal microscopy work was performed using a LSM
510 META inverted confocal scanning laser microscope
(Carl Zeiss Ltd., Germany) carried out at the Centro de
Microscopia (CEMEL), Instituto de Ciências Biológicas,
Universidade Federal de Minas Gerais, Belo Horizonte,
MG, Brazil. Randomly selected areas of each sample were
imaged using a ×63 magnification objective with a numer-
ical aperture of 1.4. Confocal illumination was provided
by a Kr/Ar laser (458-nm laser excitation) fitted with a
long-pass 520-nm emission filter (greenfluorescence sig-
nal).
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